Ina Weiner - Publications

Affiliations: 
Tel Aviv University, Tel Aviv-Yafo, Tel Aviv District, Israel 
Area:
Latent inhibition, animal models of schizophrenia, behavioral neuroscience

124 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Arad M, Piontkewitz Y, Albelda N, Shaashua L, Weiner I. Immune activation in lactating dams alters sucklings' brain cytokines and produces non-overlapping behavioral deficits in adult female and male offspring: A novel neurodevelopmental model of sex-specific psychopathology. Brain, Behavior, and Immunity. PMID 28189716 DOI: 10.1016/j.bbi.2017.01.015  1
2016 Patrich E, Piontkewitz Y, Peretz A, Weiner I, Attali B. Maternal immune activation produces neonatal excitability defects in offspring hippocampal neurons from pregnant rats treated with poly I:C. Scientific Reports. 6: 19106. PMID 26742695 DOI: 10.1038/srep19106  1
2015 Patrich E, Piontkewitz Y, Peretz A, Weiner I, Attali B. Maturation- and sex-sensitive depression of hippocampal excitatory transmission in a rat schizophrenia model. Brain, Behavior, and Immunity. PMID 26327125 DOI: 10.1016/j.bbi.2015.08.021  1
2013 Klein J, Hadar R, Götz T, Männer A, Eberhardt C, Baldassarri J, Schmidt TT, Kupsch A, Heinz A, Morgenstern R, Schneider M, Weiner I, Winter C. Mapping brain regions in which deep brain stimulation affects schizophrenia-like behavior in two rat models of schizophrenia. Brain Stimulation. 6: 490-9. PMID 23085443 DOI: 10.1016/j.brs.2012.09.004  1
2012 Griebel G, Pichat P, Pruniaux MP, Beeské S, Lopez-Grancha M, Genet E, Terranova JP, Castro A, Sánchez JA, Black M, Varty GB, Weiner I, Arad M, Barak S, De Levie A, et al. SAR110894, a potent histamine H₃-receptor antagonist, displays procognitive effects in rodents. Pharmacology, Biochemistry, and Behavior. 102: 203-14. PMID 22542742 DOI: 10.1016/j.pbb.2012.04.004  1
2012 Piontkewitz Y, Bernstein HG, Dobrowolny H, Bogerts B, Weiner I, Keilhoff G. Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain, Behavior, and Immunity. 26: 353-63. PMID 22154704 DOI: 10.1016/j.bbi.2011.11.004  1
2012 Arad M, Weiner I. Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats. Psychoneuroendocrinology. 37: 200-12. PMID 21723667 DOI: 10.1016/j.psyneuen.2011.06.004  1
2012 Piontkewitz Y, Arad M, Weiner I. Tracing the development of psychosis and its prevention: what can be learned from animal models. Neuropharmacology. 62: 1273-89. PMID 21703648 DOI: 10.1016/j.neuropharm.2011.04.019  1
2011 Piontkewitz Y, Arad M, Weiner I. Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat. Biological Psychiatry. 70: 842-51. PMID 21816387 DOI: 10.1016/j.biopsych.2011.06.007  1
2011 Barak S, Weiner I. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target. Pharmacology, Biochemistry, and Behavior. 99: 164-89. PMID 21420999 DOI: 10.1016/j.pbb.2011.03.011  1
2011 Barak S, Weiner I. The M₁/Mâ‚„ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 1233-46. PMID 21211109 DOI: 10.1017/S1461145710001549  1
2011 Black MD, Stevens RJ, Rogacki N, Featherstone RE, Senyah Y, Giardino O, Borowsky B, Stemmelin J, Cohen C, Pichat P, Arad M, Barak S, De Levie A, Weiner I, Griebel G, et al. AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. Psychopharmacology. 215: 149-63. PMID 21181124 DOI: 10.1007/s00213-010-2124-0  1
2011 Meyer U, Weiner I, McAlonan GM, Feldon J. The neuropathological contribution of prenatal inflammation to schizophrenia. Expert Review of Neurotherapeutics. 11: 29-32. PMID 21158552 DOI: 10.1586/ern.10.169  1
2011 Piontkewitz Y, Arad M, Weiner I. Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophrenia Bulletin. 37: 1257-69. PMID 20439320 DOI: 10.1093/schbul/sbq040  1
2010 Arad M, Weiner I. Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2179-92. PMID 20613719 DOI: 10.1038/npp.2010.89  1
2010 Arad M, Weiner I. Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1570-82. PMID 20237462 DOI: 10.1038/npp.2010.28  1
2010 Barak S, Weiner I. Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine. Psychopharmacology. 209: 175-84. PMID 20179909 DOI: 10.1007/s00213-010-1785-z  1
2010 Barak S, Weiner I. Differential role of muscarinic transmission within the entorhinal cortex and basolateral amygdala in the processing of irrelevant stimuli. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1073-82. PMID 20072122 DOI: 10.1038/npp.2009.210  1
2010 Lubow RE, Weiner I. Issues in latent inhibition research and theory: An overview Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia. 531-557. DOI: 10.1017/CBO9780511730184.023  1
2010 Weiner I. What the brain teaches us about latent inhibition (LI): The neural substrates of the expression and prevention of LI Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia. 372-416. DOI: 10.1017/CBO9780511730184.017  1
2010 Weiner I, Arad M. The pharmacology of latent inhibition and its relevance to schizophrenia Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia. 276-318. DOI: 10.1017/CBO9780511730184.014  1
2010 Lubow RE, Weiner I. Preface Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia. xi-xii. DOI: 10.1017/CBO9780511730184.001  1
2010 Lubow RE, Weiner I. Latent inhibition: Cognition, neuroscience and applications to schizophrenia Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia. 1-561. DOI: 10.1017/CBO9780511730184  1
2010 Piontkewitz Y, Bernstein HG, Dobrowolny H, Bogerts B, Weiner I, Keilhoff G. Time-dependent effects of risperidone on hippocampal neurogenesis in the poly I: C model of schizophrenia Acta Clinica Croatica. 49: 37-38.  1
2009 Piontkewitz Y, Assaf Y, Weiner I. Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biological Psychiatry. 66: 1038-46. PMID 19726031 DOI: 10.1016/j.biopsych.2009.07.005  1
2009 Feldon J, Weiner I. Editorial: Special issue on modeling schizophrenia. Behavioural Brain Research. 204: 255-7. PMID 19616035 DOI: 10.1016/j.bbr.2009.07.013  1
2009 Weiner I, Arad M. Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment. Behavioural Brain Research. 204: 369-86. PMID 19433114 DOI: 10.1016/j.bbr.2009.05.004  1
2009 Arad M, Weiner I. Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone. Psychopharmacology. 206: 731-40. PMID 19169876 DOI: 10.1007/s00213-009-1464-0  1
2009 Barak S, Arad M, De Levie A, Black MD, Griebel G, Weiner I. Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1753-63. PMID 19158670 DOI: 10.1038/npp.2008.232  1
2009 Black MD, Varty GB, Arad M, Barak S, De Levie A, Boulay D, Pichat P, Griebel G, Weiner I. Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology. 202: 385-96. PMID 18709358 DOI: 10.1007/s00213-008-1289-2  1
2009 Barak S, Weiner I. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 227-41. PMID 18687163 DOI: 10.1017/S1461145708009176  1
2008 Arad M, Weiner I. Fluctuation of latent inhibition along the estrous cycle in the rat: modeling the cyclicity of symptoms in schizophrenic women? Psychoneuroendocrinology. 33: 1401-10. PMID 18819755 DOI: 10.1016/j.psyneuen.2008.08.001  1
2008 Gaisler-Salomon I, Diamant L, Rubin C, Weiner I. Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology. 196: 255-67. PMID 17928997 DOI: 10.1007/s00213-007-0960-3  1
2007 Barak S, Weiner I. Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 989-99. PMID 16971898 DOI: 10.1038/sj.npp.1301208  1
2006 Schiller D, Zuckerman L, Weiner I. Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol. Journal of Psychiatric Research. 40: 167-77. PMID 15882871 DOI: 10.1016/j.jpsychires.2005.03.002  1
2005 Tarrasch R, Goelman G, Joel D, Daphna J, Weiner I. Long-term functional consequences of quinolinic acid striatal lesions and their alteration following an addition of a globus pallidus lesion assessed using pharmacological magnetic resonance imaging. Experimental Neurology. 196: 244-53. PMID 16236282 DOI: 10.1016/j.expneurol.2005.07.023  1
2005 Gal G, Schiller D, Weiner I. Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: The neural site controlling the expression and disruption of the stimulus preexposure effect. Behavioural Brain Research. 162: 246-55. PMID 15970218 DOI: 10.1016/j.bbr.2005.03.019  1
2005 Schiller D, Weiner I. Basolateral amygdala lesions in the rat produce an abnormally persistent latent inhibition with weak preexposure but not with context shift. Behavioural Brain Research. 163: 115-21. PMID 15921766 DOI: 10.1016/j.bbr.2005.04.005  1
2005 Lipina T, Labrie V, Weiner I, Roder J. Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology. 179: 54-67. PMID 15759151 DOI: 10.1007/s00213-005-2210-x  1
2005 Zuckerman L, Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. Journal of Psychiatric Research. 39: 311-23. PMID 15725430 DOI: 10.1016/j.jpsychires.2004.08.008  1
2004 Schiller D, Weiner I. Lesions to the basolateral amygdala and the orbitofrontal cortex but not to the medial prefrontal cortex produce an abnormally persistent latent inhibition in rats. Neuroscience. 128: 15-25. PMID 15450350 DOI: 10.1016/j.neuroscience.2004.06.020  1
2004 Cohen E, Sereni N, Kaplan O, Weizman A, Kikinzon L, Weiner I, Lubow RE. The relation between latent inhibition and symptom-types in young schizophrenics. Behavioural Brain Research. 149: 113-22. PMID 15129775 DOI: 10.1016/S0166-4328(03)00221-3  1
2004 Ayalon L, Doron R, Weiner I, Joel D. Amelioration of behavioral deficits in a rat model of Huntington's disease by an excitotoxic lesion to the globus pallidus. Experimental Neurology. 186: 46-58. PMID 14980809 DOI: 10.1016/S0014-4886(03)00312-1  1
2004 Pouzet B, Zhang WN, Weiner I, Feldon J, Yee BK. Latent inhibition is spared by N-methyl-D-aspartate (NMDA)-induced ventral hippocampal lesions, but is attenuated following local activation of the ventral hippocampus by intracerebral NMDA infusion. Neuroscience. 124: 183-94. PMID 14960350 DOI: 10.1016/j.neuroscience.2003.11.007  1
2003 Joel D, Ayalon L, Tarrasch R, Weiner I. Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1499-507. PMID 14673887 DOI: 10.1002/mds.10622  1
2003 Zuckerman L, Rehavi M, Nachman R, Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1778-89. PMID 12865897 DOI: 10.1038/sj.npp.1300248  1
2003 Zuckerman L, Rimmerman N, Weiner I. Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia. Psychopharmacology. 169: 298-307. PMID 12827344 DOI: 10.1007/s00213-003-1460-8  1
2003 Weiner I, Schiller D, Gaisler-Salomon I, Green A, Joel D. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine. Behavioural Pharmacology. 14: 215-22. PMID 12799523 DOI: 10.1097/01.fbp.0000069579.37661.63  1
2003 Zuckerman L, Weiner I. Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation. Psychopharmacology. 169: 308-13. PMID 12748757 DOI: 10.1007/s00213-003-1461-7  1
2003 Weiner I, Schiller D, Gaisler-Salomon I. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 499-509. PMID 12629529 DOI: 10.1038/sj.npp.1300069  1
2003 Weiner I. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology. 169: 257-97. PMID 12601500 DOI: 10.1007/s00213-002-1313-x  1
2003 Gaisler-Salomon I, Weiner I. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology. 166: 333-42. PMID 12599023 DOI: 10.1007/s00213-002-1311-z  1
2001 Weiner I. Latent inhibition. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.13. PMID 18428541 DOI: 10.1002/0471142301.ns0813s16  1
2001 Shalev U, Weiner I. Gender-dependent differences in latent inhibition following prenatal stress and corticosterone administration. Behavioural Brain Research. 126: 57-63. PMID 11704252 DOI: 10.1016/S0166-4328(01)00250-9  1
2000 Shadach E, Gaisler I, Schiller D, Weiner I. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 151-61. PMID 10882841 DOI: 10.1016/S0893-133X(00)00096-8  1
2000 Joel D, Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience. 96: 451-74. PMID 10717427 DOI: 10.1016/S0306-4522(99)00575-8  1
2000 Lacroix L, Broersen LM, Feldon J, Weiner I. Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behavioural Brain Research. 107: 111-21. PMID 10628735 DOI: 10.1016/S0166-4328(99)00118-7  1
2000 Weiner I, Gaisler I, Schiller D, Green A, Zuckerman L, Joel D. Screening of antipsychotic drugs in animal models Drug Development Research. 50: 235-249.  1
1999 Shadach E, Feldon J, Weiner I. Clozapine-induced potentiation of latent inhibition is due to its action in the conditioning stage: implications for the mechanism of action of antipsychotic drugs. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 2: 283-291. PMID 11285144 DOI: 10.1017/S1461145799001583  1
1999 Broersen LM, Feldon J, Weiner I. Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion. Neuroscience. 94: 39-46. PMID 10613495 DOI: 10.1016/S0306-4522(99)00287-0  1
1999 Zhang W, Pouzet B, Jongen-Rêlo AL, Weiner I, Feldon J. Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics. Neuroreport. 10: 2533-8. PMID 10574365  1
1999 Pouzet B, Feldon J, Veenman CL, Yee BK, Richmond M, Nicholas J, Rawlins P, Weiner I. The effects of hippocampal and fimbria-fornix lesions on prepulse inhibition. Behavioral Neuroscience. 113: 968-81. PMID 10571479 DOI: 10.1037//0735-7044.113.5.968  1
1999 Weiner I, Gal G, Feldon J. Disrupted and undisruptable latent inhibition following shell and core lesions. Annals of the New York Academy of Sciences. 877: 723-7. PMID 10415692 DOI: 10.1111/j.1749-6632.1999.tb09310.x  1
1999 Pouzet B, Veenman CL, Yee BK, Feldon J, Weiner I. The effects of radiofrequency lesion or transection of the fimbria-fornix on latent inhibition in the rat. Neuroscience. 91: 1355-68. PMID 10391442 DOI: 10.1016/S0306-4522(98)00691-5  1
1999 Della Casa V, Höfer I, Weiner I, Feldon J. Effects of smoking status and schizotypy on latent inhibition. Journal of Psychopharmacology (Oxford, England). 13: 45-57. PMID 10221359  1
1998 Shalev U, Feldon J, Weiner I. Latent inhibition is disrupted by acute and repeated administration of corticosterone. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 1: 103-113. PMID 11281953 DOI: 10.1017/S1461145798001163  1
1998 Ruob C, Weiner I, Feldon J. Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning. Behavioural Pharmacology. 9: 245-53. PMID 9832938  1
1998 Weiner I, Feldon J, Tarrasch R, Hairston I, Joel D. Fimbria-fornix cut affects spontaneous activity, two-way avoidance and delayed non matching to sample, but not latent inhibition. Behavioural Brain Research. 96: 59-70. PMID 9821543 DOI: 10.1016/S0166-4328(97)00193-9  1
1998 Shalev U, Feldon J, Weiner I. Gender- and age-dependent differences in latent inhibition following pre-weaning non-handling: implications for a neurodevelopmental animal model of schizophrenia. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 16: 279-88. PMID 9785124 DOI: 10.1016/S0736-5748(98)00031-8  1
1998 Della Casa V, Höfer I, Weiner I, Feldon J. The effects of smoking on acoustic prepulse inhibition in healthy men and women. Psychopharmacology. 137: 362-8. PMID 9676896 DOI: 10.1007/s002130050631  1
1998 Stöhr T, Schulte Wermeling D, Weiner I, Feldon J. Rat strain differences in open-field behavior and the locomotor stimulating and rewarding effects of amphetamine. Pharmacology, Biochemistry, and Behavior. 59: 813-8. PMID 9586836 DOI: 10.1016/S0091-3057(97)00542-X  1
1998 Stöhr T, Schulte Wermeling D, Szuran T, Pliska V, Domeney A, Welzl H, Weiner I, Feldon J. Differential effects of prenatal stress in two inbred strains of rats. Pharmacology, Biochemistry, and Behavior. 59: 799-805. PMID 9586834 DOI: 10.1016/S0091-3057(97)00541-8  1
1998 Lacroix L, Broersen LM, Weiner I, Feldon J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience. 84: 431-42. PMID 9539214 DOI: 10.1016/S0306-4522(97)00521-6  1
1998 Joel D, Ayalon L, Tarrasch R, Veenman L, Feldon J, Weiner I. Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease. Brain Research. 787: 143-8. PMID 9518584 DOI: 10.1016/S0006-8993(97)01428-5  1
1998 Weiner I, Hairston I, Shayit M, Feldman G, Joel D, Feldon J. Strain differences in latent inhibition Psychobiology. 26: 57-64.  1
1997 Weiner I, Bernasconi E, Broersen LM, Feldon J. Amphetamine-induced disruption of latent inhibition depends on the nature of the stimulus. Behavioural Pharmacology. 8: 442-57. PMID 9832983  1
1997 Ruob C, Elsner J, Weiner I, Feldon J. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus. Behavioural Brain Research. 88: 35-41. PMID 9401706 DOI: 10.1016/S0166-4328(97)02305-X  1
1997 Weiner I, Feldon J. The switching model of latent inhibition: an update of neural substrates. Behavioural Brain Research. 88: 11-25. PMID 9401704 DOI: 10.1016/S0166-4328(97)02314-0  1
1997 Joel D, Tarrasch R, Feldon J, Weiner I. Effects of electrolytic lesions of the medial prefrontal cortex or its subfields on 4-arm baited, 8-arm radial maze, two-way active avoidance and conditioned fear tasks in the rat. Brain Research. 765: 37-50. PMID 9310392 DOI: 10.1016/S0006-8993(97)00334-X  1
1997 Weiner I, Tarrasch R, Bernasconi E, Broersen LM, Rüttimann TC, Feldon J. Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated. Pharmacology, Biochemistry, and Behavior. 56: 817-26. PMID 9130310 DOI: 10.1016/S0091-3057(96)00417-0  1
1997 Gal G, Joel D, Gusak O, Feldon J, Weiner I. The effects of electrolytic lesion to the shell subterritory of the nucleus accumbens on delayed non-matching-to-sample and four-arm baited eight-arm radial-maze tasks. Behavioral Neuroscience. 111: 92-103. PMID 9109627 DOI: 10.1037/0735-7044.111.1.92  1
1997 Joel D, Weiner I, Feldon J. Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: implications for animal models of schizophrenia. Behavioural Brain Research. 85: 187-201. PMID 9105575 DOI: 10.1016/S0166-4328(97)87583-3  1
1997 Joel D, Weiner I. The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry. Brain Research. Brain Research Reviews. 23: 62-78. PMID 9063587 DOI: 10.1016/S0165-0173(96)00018-5  1
1997 Weiner I, Shadach E, Barkai R, Feldon J. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 16: 42-50. PMID 8981387 DOI: 10.1016/S0893-133X(96)00145-5  1
1996 Weiner I, Gal G, Rawlins JN, Feldon J. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity. Behavioural Brain Research. 81: 123-33. PMID 8950008 DOI: 10.1016/S0166-4328(96)00051-4  1
1996 Weiner I, Shadach E, Tarrasch R, Kidron R, Feldon J. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. Biological Psychiatry. 40: 834-43. PMID 8896769 DOI: 10.1016/0006-3223(95)00573-0  1
1995 Weiner I, Traub A, Rawlins JN, Smith AD, Feldon J. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats. Behavioural Pharmacology. 6: 46-54. PMID 11224311  1
1995 Weiner I, Tarrasch R, Feldon J. Basolateral amygdala lesions do not disrupt latent inhibition. Behavioural Brain Research. 72: 73-81. PMID 8788859 DOI: 10.1016/0166-4328(96)00056-3  1
1995 Gray JA, Joseph MH, Hemsley DR, Young AM, Warburton EC, Boulenguez P, Grigoryan GA, Peters SL, Rawlins JN, Taib CT. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behavioural Brain Research. 71: 19-31. PMID 8747172 DOI: 10.1016/0166-4328(95)00154-9  1
1995 Raviv A, Weiner I. Why Don't They Like Us? Psychologists' Public Image in Israel During the Persian Gulf War Professional Psychology: Research and Practice. 26: 88-94.  1
1994 Weiner I, Tarrasch R, Hasson O, Forian R, Smith AD, Rawlins JN, Feldon J. The effects of chronic administration of ceronapril on the partial reinforcement extinction effect and latent inhibition in rats. Behavioural Pharmacology. 5: 306-314. PMID 11224280  1
1994 Weiner I, Kidron R, Tarrasch R, Arnt J, Feldon J. The effects of the new antipsychotic, sertindole, on latent inhibition in rats. Behavioural Pharmacology. 5: 119-124. PMID 11224259  1
1994 Weiner I, Feldon J. The latent inhibition model of schizophrenic attention disorder and of antipsychotic drug action: comment on Dunn, Atwater and Kilts (Psychopharmacology, 1993, 112:315-323) Psychopharmacology. 116: 379-81. PMID 7892430 DOI: 10.1007/BF02245344  1
1994 Joel D, Weiner I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience. 63: 363-79. PMID 7891852 DOI: 10.1016/0306-4522(94)90536-3  1
1994 Warburton EC, Joseph MH, Feldon J, Weiner I, Gray JA. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron. Psychopharmacology. 114: 657-64. PMID 7855229 DOI: 10.1007/BF02244998  1
1992 Tarrasch R, Weiner I, Rawlins JN, Feldon J. Distribution of latent inhibition by interupting the subicular input to nucleus accumbens and its antagonism by haloperidol. Journal of Psychopharmacology (Oxford, England). 6: 111. PMID 22291270 DOI: 10.1177/026988119200600142  0.72
1992 Feldon J, Weiner I. Amphetamine and the multitrial partial reinforcement extinction effect (PREE) in an operant chamber: procedural modifications that lead to an attenuation of the PREE. Pharmacology, Biochemistry, and Behavior. 41: 309-15. PMID 1574519 DOI: 10.1016/0091-3057(92)90103-M  1
1992 Weiner I, Feldon J. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia. Pharmacology, Biochemistry, and Behavior. 42: 625-31. PMID 1513845 DOI: 10.1016/0091-3057(92)90008-4  1
1992 Feldon J, Weiner I. From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. Journal of Psychiatric Research. 26: 345-66. PMID 1491358 DOI: 10.1016/0022-3956(92)90040-U  1
1992 Weiner I, Smith AD, Rawlins JN, Feldon J. A neuroleptic-like effect of ceronapril on latent inhibition. Neuroscience. 49: 307-15. PMID 1359453 DOI: 10.1016/0306-4522(92)90098-M  1
1991 Feldon J, Weiner I. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli. Biological Psychiatry. 29: 635-46. PMID 2054435  0.64
1991 Feldon J, Weiner I. Effects of haloperidol on the multitrial partial reinforcement extinction effect (PREE): evidence for neuroleptic drug action on nonreinforcement but not on reinforcement. Psychopharmacology. 105: 407-14. PMID 1686816 DOI: 10.1007/BF02244437  1
1991 Feldon J, Shofel A, Weiner I. Latent inhibition is unaffected by direct dopamine agonists. Pharmacology, Biochemistry, and Behavior. 38: 309-14. PMID 1676170  0.64
1990 Feldon J, Avnimelech-Gigus N, Weiner I. The effects of pre- and postweaning rearing conditions on latent inhibition and partial reinforcement extinction effect in male rats. Behavioral and Neural Biology. 53: 189-204. PMID 2331231  0.64
1989 Feldon J, Weiner I. The effects of amphetamine on a multitrial partial reinforcement extinction effect (PREE) in an operant chamber. Pharmacology, Biochemistry, and Behavior. 32: 65-9. PMID 2734352  0.64
1989 Feldon J, Bercovitz H, Weiner I. The effects of amphetamine on a multitrial partial reinforcement extinction effect (PREE) in a runway. Pharmacology, Biochemistry, and Behavior. 32: 55-63. PMID 2734351  0.64
1989 Feldon J, Weiner I. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats. Pharmacology, Biochemistry, and Behavior. 32: 123-7. PMID 2734324  0.64
1988 Weiner I, Lubow RE, Feldon J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacology, Biochemistry, and Behavior. 30: 871-8. PMID 3227035 DOI: 10.1016/0091-3057(88)90113-X  1
1988 Feldon J, Weiner I. Long-term attentional deficit in nonhandled males: possible involvement of the dopaminergic system. Psychopharmacology. 95: 231-6. PMID 3137603  0.64
1988 Feldon J, Katz Y, Weiner I. The effects of haloperidol on the partial reinforcement extinction effect (PREE): implications for neuroleptic drug action on reinforcement and nonreinforcement. Psychopharmacology. 95: 528-33. PMID 2905502  0.64
1987 Weiner I, Feldon J, Bercovitz H. The abolition of the partial reinforcement extinction effect (PREE) by amphetamine: disruption of control by nonreinforcement. Pharmacology, Biochemistry, and Behavior. 27: 205-10. PMID 3628434  0.64
1987 Weiner I, Feldon J, Ziv-Harris D. Early handling and latent inhibition in the conditioned suppression paradigm. Developmental Psychobiology. 20: 233-40. PMID 3582782 DOI: 10.1002/dev.420200211  0.64
1987 Weiner I, Feldon J, Katz Y. Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats. Pharmacology, Biochemistry, and Behavior. 26: 241-6. PMID 3575349  0.64
1987 Weiner I, Feldon J, Ben-Horin E. Facilitation of discrimination transfers under amphetamine: the relative control by S+ and S- and general transfer effects. Psychopharmacology. 93: 261-7. PMID 3122260  0.64
1987 Weiner I, Feldon J. Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology. 91: 248-53. PMID 3107041  0.64
1987 Weiner I, Izraeli-Telerant A, Feldon J. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine. Psychopharmacology. 91: 345-51. PMID 3104957  0.64
1986 Weiner I, Feldon J, Ben-Shahar O. Simultaneous brightness discrimination and reversal: the effects of amphetamine administration in the two stages. Pharmacology, Biochemistry, and Behavior. 25: 939-42. PMID 3786368 DOI: 10.1016/0091-3057(86)90066-3  1
1986 Weiner I, Ben Horin E, Feldon J. Amphetamine and the overtraining reversal effect. Pharmacology, Biochemistry, and Behavior. 24: 1539-42. PMID 3737622  0.64
1986 Halevy G, Feldon J, Weiner I. The effects of clonidine on the partial reinforcement extinction effect (PREE). Psychopharmacology. 90: 95-100. PMID 3094069  0.64
1986 Weiner I, Feldon J. Reversal and nonreversal shifts under amphetamine. Psychopharmacology. 89: 355-9. PMID 3088663  0.64
1986 Weiner I, Bercovitz H, Feldon J. Amphetamine does not affect the partial punishment effect (PPE). Psychopharmacology. 88: 119-23. PMID 3080770  0.64
1985 Weiner I, Schnabel I, Lubow RE, Feldon J. The effects of early handling on latent inhibition in male and female rats. Developmental Psychobiology. 18: 291-7. PMID 4043546 DOI: 10.1002/dev.420180402  1
1985 Weiner I, Bercovitz H, Lubow RE, Feldon J. The abolition of the partial reinforcement extinction effect (PREE) by amphetamine. Psychopharmacology. 86: 318-23. PMID 3929302 DOI: 10.1007/BF00432221  1
1984 Weiner I, Lubow RE, Feldon J. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology. 83: 194-9. PMID 6431473 DOI: 10.1007/BF00429734  1
Show low-probability matches.